Boston An independent LDT provider

Press releases

May 28, 2021

CEO Patrik Dahlen purchases Immunovia shares

Read press release
May 27, 2021

Immunovia to Host a Key Opinion Leader Event on the Clinical Use of IMMray™ PanCan-d

Read press release
May 12, 2021

Member of Immunovia’s Board of Directors purchases shares in the company

Read press release
May 6, 2021 | REGULATORY

Annual General Meeting – Immunovia AB

Read press release
May 4, 2021

Members of Immunovia’s Board of Directors purchase shares in the company

Read press release
April 28, 2021 | REGULATORY

Immunovia Reports Interim Report January – March 2021

Read press release
April 22, 2021

Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test

Read press release
April 21, 2021 | REGULATORY

Immunovia presents update on US market size for IMMray™ PanCan-d in the familial/hereditary risk group

Read press release
April 21, 2021

Invitation to Presentation of Immunovia’s Interim Report January – March 2021

Read press release
April 16, 2021

IMMray™ PanCan-d highlighted in meeting arranged by Pancreatic Cancer Action Network

Read press release
March 31, 2021 | REGULATORY

KALLELSE TILL ÅRSSTÄMMA I IMMUNOVIA AB

Read press release
March 29, 2021 | REGULATORY

Immunovia reports positive results of the blinded clinical validation of IMMray[TM] PanCan-d blood test in USA

Read press release
1 2 3 4 5 6 22